DSC-MRI Measures of Standardized RCBV Predict Response to Bevacizumab in High-Grade Brain Tumor Patients

Keywords

abnormal administered advanced advancing agent annual anti apparent approved assistance audience automatic automatically barrier becoming began biology blood bolus brain bright cancer cell cerebral chemotherapy clear cohort collection college combination confirm consent contrast corrected date days decrease decreased decreases decreasing degree derived described determine determined distinguish dose either eliminated endothelial enhancing enrolled evaluate examples flair funding future grade growth healthier highly include injection interestingly larger leakage loading longer male maps mark matrix measures median medical meeting need neurology neurosurgery normalize oncologists oncology overall patient patients percent permeability peter planned post precludes predict predicted predictive predicts previous previously prior products program promising quickly radiation radiologists radiology rand reduce registered reliable resection respectively response role routinely scientists select sensitivity separately specificity spin standardization standardized start starting statistically studies supervised support surgeons survival systems target targets therapy thirty threshold translational treatment tumor underwent variable varied vascular versus visit volume volumes wade